Open in app

As stated in the INSACOG advisory, BA.2.38 has not increased hospitalizations or illness severity

img-1
Total Views:
12
img-1
Total Likes:
0
img-1
Published By:
Peeyush Ghalot
img-1
Published On:
11-07-2022
(Photo Courtesy: - Freshers live)

The child of the Hindu Omicron sub-variant BA.2 A few recent fatalities recorded are related to comorbidities, not BA.2.38, and neither hospitalizations nor disease severity have increased as a result of BA.2.38. Many BA.2 cases have been categorised as BA.2.38, according to the Indian SARS-CoV-2 Genomics Consortium (INSACOG) in the bulletin. According on the most recent sequencing batches, BA.2.38 appears to be the dominant sub-lineage. However, there have been no reports of a rise in hospitalizations or a worsening in illness severity as a result of this thus far. Comorbidities are to blame for a few recent fatalities that have been documented. Being COVID-appropriate is still advised since it is likely to stop the illness from spreading. Hospitalization because of the disease's severity hasn't been seen very often, though. INSACOG is keeping a careful eye on the current circumstance. The INSACOG stated that three cases of BA.5 and five cases of BA.4 had been recorded in India as of May 30 in another bulletin. By sequencing samples from sentinel locations and foreign travellers arriving in India, the INSACOG reports genomic monitoring of SARS-CoV-2 across the nation.

Reference: - https://www.thehindu.com/sci-tech/health/ba238-has-not-led-to-any-increase-in-hospitalisation-disease-severity-insacog-bulletin/article65622946.ece